LY294002也写作LY-294,002,LY-294002或LY 294002,是一种常用的phosphatidylinositol 3-kinase (PI3K)抑制剂。
LY294002可以通透细胞,特异性抑制PI3K,抑制PI3K/Akt信号途径,包括常见的抑制Akt磷酸化等。LY294002对于纯化的PI3K的IC50为1.4 μM。
LY294002分子量为307.3,分子式为C19H17NO3,CAS Number:154447-36-6。本产品纯度大于98%。
本LY294002为进口分装,其中10mg/ml包装产品用DMSO配制,共0.1ml。5mg和25mg包装为粉末装。
包装清单:
产品编号 | 产品名称 | 包装 |
S1737-1mg | LY294002 (PI3K抑制剂) | 10mg/ml×0.1ml |
S1737-5mg | LY294002 (PI3K抑制剂) | 5mg |
S1737-25mg | LY294002 (PI3K抑制剂) | 25mg |
— | 说明书 | 1份 |
保存条件:
-20℃保存,半年有效。
注意事项:
本LY294002在4℃、冰浴等较低温度情况下会凝固而粘在离心管管底、管壁或管盖内,可以20-25℃水浴温育片刻至全部融解后使用。
本产品仅限于专业人员的科学研究用,不得用于临床诊断或治疗,不得用于食品或药品,不得存放于普通住宅内。
为了您的安全和健康,请穿实验服并戴一次性手套操作。
产品编号
|
产品名称
|
产品包装
|
S1737-1mg
|
LY294002 (PI3K抑制剂)
|
10mg/ml×0.1ml
|
S1737-5mg
|
LY294002 (PI3K抑制剂)
|
5mg
|
S1737-25mg
|
LY294002 (PI3K抑制剂)
|
25mg
|
S1786-10μg
|
Okadaic
acid钾盐(PP1和PP2A抑制剂)
|
10μg
|
S1786-50μg
|
Okadaic
acid钾盐(PP1和PP2A抑制剂)
|
50μg
|
S1786-250μg
|
Okadaic
acid钾盐(PP1和PP2A抑制剂)
|
250μg
|
S1786-1mg
|
Okadaic
acid钾盐(PP1和PP2A抑制剂)
|
1mg
|
S1952
|
Wortmannin (PI3K抑制剂)
|
0.5mg
|
SC0227-10mM
|
Perifosine (Akt抑制剂)
|
10mM×0.2ml
|
SC0227-5mg
|
Perifosine (Akt抑制剂)
|
5mg
|
SC0227-25mg
|
Perifosine (Akt抑制剂)
|
25mg
|
SC9123-10mM
|
GW9662 (PPAR拮抗剂)
|
10mM
|
SC9123-5mg
|
GW9662 (PPAR拮抗剂)
|
5mg
|
SC9123-25mg
|
GW9662 (PPAR拮抗剂)
|
25mg
|
SC9136-10mM
|
KU-55933 (ATM抑制剂)
|
10mM
|
SC9136-5mg
|
KU-55933 (ATM抑制剂)
|
5mg
|
SC9136-25mg
|
KU-55933 (ATM抑制剂)
|
25mg
|
SC9145-10mM
|
Rucaparib (PARP抑制剂)
|
10mM
|
SC9145-5mg
|
Rucaparib (PARP抑制剂)
|
5mg
|
SC9145-25mg
|
Rucaparib (PARP抑制剂)
|
25mg
|
SC9150-10mM
|
NU7026 (DNA-PK抑制剂)
|
10mM
|
SC9150-5mg
|
NU7026 (DNA-PK抑制剂)
|
5mg
|
SC9150-25mg
|
NU7026 (DNA-PK抑制剂)
|
25mg
|
SC9154-10mM
|
NU-7441 (DNA-PK抑制剂)
|
10mM
|
SC9154-5mg
|
NU-7441 (DNA-PK抑制剂)
|
5mg
|
SC9154-25mg
|
NU-7441 (DNA-PK抑制剂)
|
25mg
|
SD0020-10mM
|
Chlorotrianisene
(Estrogen Receptor调节剂)
|
10mM
|
SD0020-5mg
|
Chlorotrianisene
(Estrogen Receptor调节剂)
|
5mg
|
SD0020-25mg
|
Chlorotrianisene
(Estrogen Receptor调节剂)
|
25mg
|
SD7189-10mM
|
WY-14643 (PPAR激活剂)
|
10mM
|
SD7189-5mg
|
WY-14643 (PPAR激活剂)
|
5mg
|
SD7189-25mg
|
WY-14643 (PPAR激活剂)
|
25mg
|
SF1082-10mM
|
LB-100 (PP2A抑制剂)
|
10mM
|
SF1082-5mg
|
LB-100 (PP2A抑制剂)
|
5mg
|
SF1082-25mg
|
LB-100 (PP2A抑制剂)
|
25mg
|
SF2663-10mM
|
IM-12 (GSK-3抑制剂)
|
10mM
|
SF2663-5mg
|
IM-12 (GSK-3抑制剂)
|
5mg
|
SF2663-25mg
|
IM-12 (GSK-3抑制剂)
|
25mg
|
SF2667-10mM
|
A66 (PI3K抑制剂)
|
10mM
|
SF2667-5mg
|
A66 (PI3K抑制剂)
|
5mg
|
SF2667-25mg
|
A66 (PI3K抑制剂)
|
25mg
|
SF2676-10mM
|
AZ20 (ATM/ATR抑制剂)
|
10mM
|
SF2676-5mg
|
AZ20 (ATM/ATR抑制剂)
|
5mg
|
SF2676-25mg
|
AZ20 (ATM/ATR抑制剂)
|
25mg
|
SF2690-10mM
|
PI-103 (PI3K抑制剂)
|
10mM
|
SF2690-5mg
|
PI-103 (PI3K抑制剂)
|
5mg
|
SF2690-25mg
|
PI-103 (PI3K抑制剂)
|
25mg
|
SF2694-10mM
|
CAL-101 (PI3K抑制剂)
|
10mM
|
SF2694-5mg
|
CAL-101 (PI3K抑制剂)
|
5mg
|
SF2694-25mg
|
CAL-101 (PI3K抑制剂)
|
25mg
|
SF2703-10mM
|
CHIR-99021 HCl
(GSK-3抑制剂)
|
10mM
|
SF2703-5mg
|
CHIR-99021 HCl
(GSK-3抑制剂)
|
5mg
|
SF2703-25mg
|
CHIR-99021 HCl
(GSK-3抑制剂)
|
25mg
|
SF2708-10mM
|
CHIR-99021 (GSK-3抑制剂)
|
10mM
|
SF2708-5mg
|
CHIR-99021 (GSK-3抑制剂)
|
5mg
|
SF2708-25mg
|
CHIR-99021 (GSK-3抑制剂)
|
25mg
|
SF2712-10mM
|
MK2206 (Akt抑制剂)
|
10mM
|
SF2712-5mg
|
MK2206 (Akt抑制剂)
|
5mg
|
SF2712-25mg
|
MK2206 (Akt抑制剂)
|
25mg
|
SF2717-10mM
|
GDC0941 (PI3K抑制剂)
|
10mM
|
SF2717-5mg
|
GDC0941 (PI3K抑制剂)
|
5mg
|
SF2717-25mg
|
GDC0941 (PI3K抑制剂)
|
25mg
|
SF2721-10mM
|
Triciribine (Akt抑制剂)
|
10mM
|
SF2721-5mg
|
Triciribine (Akt抑制剂)
|
5mg
|
SF2721-25mg
|
Triciribine (Akt抑制剂)
|
25mg
|
SF2726-10mM
|
BKM120 (PI3K抑制剂)
|
10mM
|
SF2726-5mg
|
BKM120 (PI3K抑制剂)
|
5mg
|
SF2726-25mg
|
BKM120 (PI3K抑制剂)
|
25mg
|
SF2730-10mM
|
SC79 (Akt激活剂)
|
10mM
|
SF2730-5mg
|
SC79 (Akt激活剂)
|
5mg
|
SF2730-25mg
|
SC79 (Akt激活剂)
|
25mg
|
SF2735-10mM
|
CP21R7 (GSK-3β抑制剂)
|
10mM
|
SF2735-5mg
|
CP21R7 (GSK-3β抑制剂)
|
5mg
|
SF2735-25mg
|
CP21R7 (GSK-3β抑制剂)
|
25mg
|
SF2744-10mM
|
AR-A014418 (GSK-3抑制剂)
|
10mM
|
SF2744-5mg
|
AR-A014418 (GSK-3抑制剂)
|
5mg
|
SF2744-25mg
|
AR-A014418 (GSK-3抑制剂)
|
25mg
|
SF2753-10mM
|
BYL719 (PI3K抑制剂)
|
10mM
|
SF2753-5mg
|
BYL719 (PI3K抑制剂)
|
5mg
|
SF2753-25mg
|
BYL719 (PI3K抑制剂)
|
25mg
|
SF2762-10mM
|
OSU-03012 (PDK-1抑制剂)
|
10mM
|
SF2762-5mg
|
OSU-03012 (PDK-1抑制剂)
|
5mg
|
SF2762-25mg
|
OSU-03012 (PDK-1抑制剂)
|
25mg
|
SF2766-10mM
|
TDZD-8 (GSK-3抑制剂)
|
10mM
|
SF2766-5mg
|
TDZD-8 (GSK-3抑制剂)
|
5mg
|
SF2766-25mg
|
TDZD-8 (GSK-3抑制剂)
|
25mg
|
SF2771-10mM
|
TWS119 (GSK-3抑制剂)
|
10mM
|
SF2771-5mg
|
TWS119 (GSK-3抑制剂)
|
5mg
|
SF2771-25mg
|
TWS119 (GSK-3抑制剂)
|
25mg
|
SF2775-10mM
|
Pilaralisib (PI3K抑制剂)
|
10mM
|
SF2775-5mg
|
Pilaralisib (PI3K抑制剂)
|
5mg
|
SF2775-25mg
|
Pilaralisib (PI3K抑制剂)
|
25mg
|
SF2784-10mM
|
AKT inhibitor VIII
(Akt抑制剂)
|
10mM
|
SF2784-5mg
|
AKT inhibitor VIII
(Akt抑制剂)
|
5mg
|
SF2784-25mg
|
AKT inhibitor VIII
(Akt抑制剂)
|
25mg
|
SF2789-10mM
|
GSK690693 (Akt抑制剂)
|
10mM
|
SF2789-5mg
|
GSK690693 (Akt抑制剂)
|
5mg
|
SF2789-25mg
|
GSK690693 (Akt抑制剂)
|
25mg
|
SF2802-10mM
|
TGX221 (PI3K抑制剂)
|
10mM
|
SF2802-5mg
|
TGX221 (PI3K抑制剂)
|
5mg
|
SF2802-25mg
|
TGX221 (PI3K抑制剂)
|
25mg
|
SF2811-10mM
|
GSK2126458 (PI3K抑制剂)
|
10mM
|
SF2811-5mg
|
GSK2126458 (PI3K抑制剂)
|
5mg
|
SF2811-25mg
|
GSK2126458 (PI3K抑制剂)
|
25mg
|
SF2820-10mM
|
AZD5363 (Akt抑制剂)
|
10mM
|
SF2820-5mg
|
AZD5363 (Akt抑制剂)
|
5mg
|
SF2820-25mg
|
AZD5363 (Akt抑制剂)
|
25mg
|
SF2825-10mM
|
GSK2141795 (Akt抑制剂)
|
10mM
|
SF2825-5mg
|
GSK2141795 (Akt抑制剂)
|
5mg
|
SF2825-25mg
|
GSK2141795 (Akt抑制剂)
|
25mg
|
SF5337-10mM
|
R428 (Axl抑制剂)
|
10mM
|
SF5337-5mg
|
R428 (Axl抑制剂)
|
5mg
|
SF5337-25mg
|
R428 (Axl抑制剂)
|
25mg
|
SF5359-10mM
|
Masitinib (c-Kit抑制剂)
|
10mM
|
SF5359-5mg
|
Masitinib (c-Kit抑制剂)
|
5mg
|
SF5359-25mg
|
Masitinib (c-Kit抑制剂)
|
25mg
|
SF5422-10mM
|
Amuvatinib (c-Kit抑制剂)
|
10mM
|
SF5422-5mg
|
Amuvatinib (c-Kit抑制剂)
|
5mg
|
SF5422-25mg
|
Amuvatinib (c-Kit抑制剂)
|
25mg
|